Guerilla Investing

Health insurers and doctors in the United States are turning up their noses at AstraZeneca’s much-vaunted new heart drug, according to a leading broker. Analysts at Société Générale forecast yesterday that sales of Brilinta...

Barclays was hit by further damaging revelations about the culture that was allowed to flourish in certain parts of the bank yesterday after it emerged that a senior executive had suppressed a damaging report...

Yes it’s here again back by popular demand the famous BMD smallcap oil & Gas round up. There are many pretenders to the Throne. But alas there can can only be one. Antrim Energy...

Today we received a letter from Sefton Resources legal mouth-piece Helen Skinner of Pinsent Masons. The letter basically threatens legal action regarding what they say are “untrue statements which wrongly damage our clients good...

China’s economy slid to its slowest growth in more than a decade last year, dragged down by global woes and a domestic campaign to deflate a property bubble. But the country finished 2012 on...

Europe, Japan and India on Thursday joined the United States in grounding their fleet of Boeing Dreamliner 787s, a day after a Japanese aircraft was forced to make an emergency landing. Japanese Transport Ministry...

The new boss of AstraZeneca has dismissed two of the drugs company’s leadership team as part of a shake-up intended to tackle flagging sales and scientific setbacks. The head of research and development, Martin...

HMV, the high-street music and DVD store, is set to collapse into administration today, putting 4,000 jobs at risk. The looming failure of the entertainment chain, which was founded in 1921 and has 235...